Form 4: Columbia Financial CEO Acquires Additional Shares Through Deferral Plan
Insider Transaction Report
Columbia Financial, Inc.'s President and CEO, Thomas J. Kemly, reported the acquisition of 127.0176 shares of common stock through a non-discretionary stock-based deferral plan.
Summary
- Thomas J. Kemly, President & CEO and Director of Columbia Financial, Inc. (CLBK), acquired 127.0176 shares of common stock on July 25, 2025.
- The shares were purchased at a price of $14.07 per share.
- This acquisition was made on a non-discretionary basis by the trustee of the Bank's rabbi trust, maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan.
- Following this transaction, Mr. Kemly's beneficial ownership includes 65,195.4651 shares indirectly held via the Stock-Based Deferral Plan.
- Additional indirect holdings include 40,946 shares via 401(k), 7,620 shares via ESOP, 32,597 shares via SERP, 41,572 shares via SIM, 5,933 shares via Spouse, 43,411 shares via Stock Award II, 50,686 shares via Stock Award III, and 54,690 shares via Stock Award IV.
- Mr. Kemly also holds significant derivative securities, including 656,471 stock options exercisable at $15.60 (fully vested), 37,894 options at $15.94 (vesting commenced May 1, 2024), 37,168 options at $16.49 (vesting commences March 6, 2025), and 94,749 options at $16.23 (vesting commences March 3, 2026).
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as it reflects an executive's acquisition of shares, albeit a small amount through a compensation plan, which generally aligns management interests with shareholders. It is a routine disclosure and does not indicate any significant new developments.
Positives
- The acquisition of additional shares by the President and CEO, even through a deferral plan, indicates continued alignment of management's interests with shareholder value.
- The existence of various stock-based compensation plans (Stock-Based Deferral Plan, 401(k), ESOP, SERP, SIM, Stock Awards, Stock Options) suggests a robust executive compensation structure designed to incentivize long-term performance.
Future Outlook
The filing primarily details past and future vesting schedules for various stock awards and options, indicating a structured long-term incentive plan for the executive. It does not provide broader forward-looking statements on company performance or strategic direction.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies. It reflects a standard executive compensation practice within the financial services industry, where stock-based incentives are used to align management interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: The transaction reinforces the alignment of the CEO's financial interests with the company's stock performance, potentially fostering confidence in long-term value creation.
Next Steps
- Continued vesting of stock options: 37,894 options commencing May 1, 2024; 37,168 options commencing March 6, 2025; and 94,749 options commencing March 3, 2026.
- Continued vesting of Stock Award II (remaining 75% upon performance achievement), Stock Award III (remaining 75% upon performance achievement), and Stock Award IV (upon performance achievement by March 3, 2028).
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date exercisable for 656,471 stock options, which are fully vested. |
| 05/01/2024 | Commencement of vesting for 37,894 stock options and 25% of Stock Award II. |
| 03/06/2025 | Commencement of vesting for 37,168 stock options and 25% of Stock Award III. |
| 07/25/2025 | Date of acquisition of 127.0176 shares of Common Stock via Stock-Based Deferral Plan. |
| 07/29/2025 | Signature date of the filing. |
| 03/03/2026 | Commencement of vesting for 94,749 stock options. |
| 03/03/2028 | Vesting date for Stock Award IV upon achievement of performance criteria. |
| 07/23/2029 | Expiration date for 656,471 stock options. |
| 05/01/2033 | Expiration date for 37,894 stock options. |
| 03/06/2034 | Expiration date for 37,168 stock options. |
| 03/03/2035 | Expiration date for 94,749 stock options. |
Recommendation
holdThis Form 4 filing details a routine, compensation-related acquisition of a small number of shares by the CEO. While it indicates continued alignment of management interests, it does not present new material information or a significant change in beneficial ownership that would warrant a strong buy or sell recommendation. The information is consistent with standard executive compensation practices and does not suggest any immediate catalysts for significant share price movement.
Keywords
Columbia Financial Inc., CLBK, SEC Form 4, Insider Trading, Executive Compensation, Stock Options, Stock Awards, Beneficial Ownership, Phantom Stock, Deferral Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.